Form 4: Artivion SVP, Clinical & MD Affairs, Marshall S. Stanton, Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc., sold 465 shares of common stock on February 27, 2024, to cover tax withholding obligations upon the vesting of performance stock units.
Summary
- On February 27, 2024, Marshall S. Stanton, SVP, Clinical & MD Affairs at Artivion, Inc. (AORT), sold 465 shares of common stock.
- The shares were sold at a price of $19.8344 per share.
- The transaction was executed to cover tax withholding obligations arising from the vesting of performance stock units.
- Following the transaction, Stanton beneficially owns 81,220 shares of Artivion, Inc.
- The sale was a 'sell to cover' transaction and does not represent a discretionary transaction.
Sentiment
Score: 5
Explanation: Neutral sentiment as the filing relates to a routine stock sale for tax purposes.
Industry Context
Form 4 filings are standard disclosures required by the SEC when corporate insiders buy or sell their company's stock; this provides transparency to the market.
Stakeholder Impact
- The transaction is unlikely to have a significant impact on stakeholders as it is a routine sale to cover tax obligations.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of the stock sale transaction. |
| 02/29/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.